gefitinib has been researched along with ag-213 in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (ag-213) | Trials (ag-213) | Recent Studies (post-2010) (ag-213) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 224 | 0 | 4 |
| Protein | Taxonomy | gefitinib (IC50) | ag-213 (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 3.222 | |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 5.7 | |
| Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | 3.0667 | |
| Protein kinase C alpha type | Homo sapiens (human) | 3 | |
| Protein-glutamine gamma-glutamyltransferase 2 | Homo sapiens (human) | 3 | |
| M-phase inducer phosphatase 1 | Homo sapiens (human) | 3 | |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | 3 | |
| Receptor-type tyrosine-protein phosphatase eta | Homo sapiens (human) | 3 | |
| Receptor protein-tyrosine kinase | Homo sapiens (human) | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Löwe, W; Lüth, A | 1 |
1 other study(ies) available for gefitinib and ag-213
| Article | Year |
|---|---|
Syntheses of 4-(indole-3-yl)quinazolines: a new class of epidermal growth factor receptor tyrosine kinase inhibitors.
Topics: Cell Line, Tumor; ErbB Receptors; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Protein Kinase Inhibitors; Quinazolines | 2008 |